Analyze Diet
Osteoarthritis and cartilage open2021; 3(3); 100193; doi: 10.1016/j.ocarto.2021.100193

Regulatory T cells provide chondroprotection through increased TIMP1, IL-10 and IL-4, but cannot mitigate the catabolic effects of IL-1β and IL-6 in a tri-culture model of osteoarthritis.

Abstract: To gain insight into Treg interactions with synovial tissues in early OA, an equine tri-culture model of OA was used to test the hypothesis that Tregs, in the absence of T Helper 17 ​cells, are sufficient to resolve inflammation elicited by IL-1β. Unassigned: To model normal and OA joints, synoviocytes were co-cultured with chondrocytes in a transwell system and ± stimulated with IL-1β. Tregs were activated and enriched, then added to co-cultures, creating tri-cultures. At culture end, synoviocytes and chondrocytes were analyzed for gene expression, Treg Foxp3 expression was reexamined by flow cytometry, and conditioned media were evaluated by ELISA. Unassigned: Tregs increased IL-10 and IL-4 in tri-culture media and increased gene expression in synoviocytes and chondrocytes. Tregs increased IL-6 in conditioned media and gene expression in synoviocytes, which was additive with IL-1β. In chondrocytes, addition of Tregs decreased gene expression while gene expression was decreased by IL-1β and addition of Tregs. IL-17A was detected in tri-cultures. CCL2 and CCL5 were increased in tri-cultures. Unassigned: In a tri-culture model of OA, addition of Tregs resulted in conditions conducive to chondroprotection including increased concentration of IL-10 and IL-4 in conditioned media and increased gene expression of in both chondrocytes and synoviocytes. However, there was increased concentration of the catabolic cytokine IL-6, and decreased gene expression of and in IL-1β-stimulated chondrocytes. These results suggest that blocking IL-6 could enhance Treg function in mitigating OA progression.
Publication Date: 2021-07-16 PubMed ID: 36474817PubMed Central: PMC9718146DOI: 10.1016/j.ocarto.2021.100193Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores how regulatory T cells (Tregs) interact with synovial tissues in the early stages of osteoarthritis (OA) and their potential effect in mitigating OA progression.

Research Methods

  • The researchers used an equine tri-culture model of OA to test their hypothesis that Tregs, when affecting the system without T Helper 17 cells, can resolve inflammation caused by IL-1β.
  • The model attempted to replicate both normal and OA joints using synoviocytes, cells found in the synovial membrane of joints, and chondrocytes, the cells found in healthy cartilage.
  • These cells were stimulated with IL-1β and then Tregs, which had been enriched and activated, were added to the co-cultures creating tri-cultures.
  • At the end of the culture period, the team analyzed gene expression in the synoviocytes and chondrocytes, reexamined Treg Foxp3 expression by flow cytometry and assessed the conditioned media using an ELISA (Enzyme-Linked Immunosorbent Assay).

Findings

  • It was found that Tregs increased levels of IL-10 and IL-4 in tri-culture media and increased gene expression in synoviocytes and chondrocytes. These cytokines have been associated with anti-inflammatory responses in the body, indicating a potentially positive role by Tregs.
  • Tregs also increased the concentration of IL-6, another cytokine, in the conditioned media, and gene expression in synoviocytes. Interestingly, this effect was also seen with IL-1β, suggesting a complex interaction of these proteins.
  • Furthermore, the researchers observed an increased gene expression of molecules associated with inflammation – CCL2 and CCL5, when Tregs were present.
  • Lastly, while Tregs decreased specific gene expression in chondrocytes, they couldn’t suppress the gene expression decrease caused by the presence of IL-1β.

Conclusion

  • In conclusion, the research shows that when Tregs are added to a tri-culture model of osteoarthritis, conditions conducive to the protection of cartilage are created, which is presumably through the increased concentration of IL-10 and IL-4 and increased gene expression in both synoviocytes and chondrocytes.
  • However, Tregs also resulted in an increase in IL-6, a catabolic cytokine linked to tissue breakdown, and decreased gene expression in IL-1β-stimulated chondrocytes. This leads to the suggestion that blocking IL-6 could potentially enhance the effectiveness of Tregs in delaying or stopping the progression of osteoarthritis.

Cite This Article

APA
Keller LE, Tait Wojno ED, Begum L, Fortier LA. (2021). Regulatory T cells provide chondroprotection through increased TIMP1, IL-10 and IL-4, but cannot mitigate the catabolic effects of IL-1β and IL-6 in a tri-culture model of osteoarthritis. Osteoarthr Cartil Open, 3(3), 100193. https://doi.org/10.1016/j.ocarto.2021.100193

Publication

ISSN: 2665-9131
NlmUniqueID: 101767068
Country: England
Language: English
Volume: 3
Issue: 3
Pages: 100193
PII: 100193

Researcher Affiliations

Keller, Laura E
  • Cornell University, College of Veterinary Medicine, Department of Clinical Sciences, USA.
Tait Wojno, Elia D
  • University of Washington, Department of Immunology, USA.
Begum, Laila
  • Cornell University, College of Veterinary Medicine, Department of Clinical Sciences, USA.
Fortier, Lisa A
  • Cornell University, College of Veterinary Medicine, Department of Clinical Sciences, USA.

References

This article includes 50 references
  1. Li YS, Luo W, Zhu SA, Lei GH. T Cells in Osteoarthritis: Alterations and Beyond.. Front Immunol 2017;8:356.
    doi: 10.3389/fimmu.2017.00356pmc: PMC5371609pubmed: 28424692google scholar: lookup
  2. Ribel-Madsen S, Bartels EM, Stockmarr A, Borgwardt A, Cornett C, Danneskiold-Samsøe B, Bliddal H. A synoviocyte model for osteoarthritis and rheumatoid arthritis: response to Ibuprofen, betamethasone, and ginger extract-a cross-sectional in vitro study.. Arthritis 2012;2012:505842.
    doi: 10.1155/2012/505842pmc: PMC3546442pubmed: 23365744google scholar: lookup
  3. Tang CH, Hsu CJ, Fong YC. The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts.. Arthritis Rheum 2010 Dec;62(12):3615-24.
    doi: 10.1002/art.27755pubmed: 20862675google scholar: lookup
  4. Wu CL, Harasymowicz NS, Klimak MA, Collins KH, Guilak F. The role of macrophages in osteoarthritis and cartilage repair.. Osteoarthritis Cartilage 2020 May;28(5):544-554.
    doi: 10.1016/j.joca.2019.12.007pmc: PMC7214213pubmed: 31926267google scholar: lookup
  5. Moran EM, Mullan R, McCormick J, Connolly M, Sullivan O, Fitzgerald O, Bresnihan B, Veale DJ, Fearon U. Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.. Arthritis Res Ther 2009;11(4):R113.
    doi: 10.1186/ar2772pmc: PMC2745795pubmed: 19627579google scholar: lookup
  6. Hot A, Zrioual S, Toh ML, Lenief V, Miossec P. IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes.. Ann Rheum Dis 2011 Feb;70(2):341-8.
    doi: 10.1136/ard.2010.132233pubmed: 21109515google scholar: lookup
  7. Penatti A, Facciotti F, De Matteis R, Larghi P, Paroni M, Murgo A, De Lucia O, Pagani M, Pierannunzii L, Truzzi M, Ioan-Facsinay A, Abrignani S, Geginat J, Meroni PL. Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis.. Arthritis Res Ther 2017 May 19;19(1):103.
    doi: 10.1186/s13075-017-1305-1pmc: PMC5437517pubmed: 28526072google scholar: lookup
  8. Moradi B, Schnatzer P, Hagmann S, Rosshirt N, Gotterbarm T, Kretzer JP, Thomsen M, Lorenz HM, Zeifang F, Tretter T. CD4⁺CD25⁺/highCD127low/⁻ regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints--analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood.. Arthritis Res Ther 2014 Apr 17;16(2):R97.
    doi: 10.1186/ar4545pmc: PMC4060198pubmed: 24742142google scholar: lookup
  9. Jung MK, Kwak JE, Shin EC. IL-17A-Producing Foxp3(+) Regulatory T Cells and Human Diseases.. Immune Netw 2017 Oct;17(5):276-286.
    doi: 10.4110/in.2017.17.5.276pmc: PMC5662777pubmed: 29093649google scholar: lookup
  10. Sharabi A, Tsokos MG, Ding Y, Malek TR, Klatzmann D, Tsokos GC. Regulatory T cells in the treatment of disease.. Nat Rev Drug Discov 2018 Nov;17(11):823-844.
    doi: 10.1038/nrd.2018.148pubmed: 30310234google scholar: lookup
  11. Panduro M, Benoist C, Mathis D. Tissue Tregs.. Annu Rev Immunol 2016 May 20;34:609-33.
  12. Cho J, Kuswanto W, Benoist C, Mathis D. T cell receptor specificity drives accumulation of a reparative population of regulatory T cells within acutely injured skeletal muscle.. Proc Natl Acad Sci U S A 2019 Dec 26;116(52):26727-26733.
    doi: 10.1073/pnas.1914848116pmc: PMC6936428pubmed: 31822623google scholar: lookup
  13. Rosshirt N, Trauth R, Platzer H, Tripel E, Nees TA, Lorenz HM, Tretter T, Moradi B. Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis.. Arthritis Res Ther 2021 Jan 22;23(1):37.
    doi: 10.1186/s13075-020-02410-wpmc: PMC7821658pubmed: 33482899google scholar: lookup
  14. Shevyrev D, Tereshchenko V. Treg Heterogeneity, Function, and Homeostasis.. Front Immunol 2019;10:3100.
    doi: 10.3389/fimmu.2019.03100pmc: PMC6971100pubmed: 31993063google scholar: lookup
  15. Ferreira LMR, Muller YD, Bluestone JA, Tang Q. Next-generation regulatory T cell therapy.. Nat Rev Drug Discov 2019 Oct;18(10):749-769.
    doi: 10.1038/s41573-019-0041-4pmc: PMC7773144pubmed: 31541224google scholar: lookup
  16. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.. Crit Rev Immunol 2012;32(1):23-63.
  17. Ortved KF, Begum L, Stefanovski D, Nixon AJ. AAV-mediated Overexpression of IL-10 Mitigates the Inflammatory Cascade in Stimulated Equine Chondrocyte Pellets.. Curr Gene Ther 2018;18(3):171-179.
  18. Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis.. Cytokine 2000 Jul;12(7):1092-9.
    doi: 10.1006/cyto.2000.0681pubmed: 10880256google scholar: lookup
  19. Zhang X, Mao Z, Yu C. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.. J Orthop Res 2004 Jul;22(4):742-50.
    doi: 10.1016/j.orthres.2003.12.007pubmed: 15183429google scholar: lookup
  20. Bigoni M, Sacerdote P, Turati M, Franchi S, Gandolla M, Gaddi D, Moretti S, Munegato D, Augusti CA, Bresciani E, Omeljaniuk RJ, Locatelli V, Torsello A. Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury.. J Orthop Res 2013 Feb;31(2):315-21.
    doi: 10.1002/jor.22208pubmed: 22886741google scholar: lookup
  21. Schnabel LV, Pezzanite LM, Antczak DF, Felippe MJ, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.. Stem Cell Res Ther 2014 Jan 24;5(1):13.
    doi: 10.1186/scrt402pmc: PMC4055004pubmed: 24461709google scholar: lookup
  22. Hamza E, Mirkovitch J, Steinbach F, Marti E. Regulatory T cells in early life: comparative study of CD4+CD25high T cells from foals and adult horses.. PLoS One 2015;10(3):e0120661.
  23. Lin Z, Fitzgerald JB, Xu J, Willers C, Wood D, Grodzinsky AJ, Zheng MH. Gene expression profiles of human chondrocytes during passaged monolayer cultivation.. J Orthop Res 2008 Sep;26(9):1230-7.
    doi: 10.1002/jor.20523pubmed: 18404652google scholar: lookup
  24. Rosengren S, Boyle DL, Firestein GS. Acquisition, culture, and phenotyping of synovial fibroblasts.. Methods Mol Med 2007;135:365-75.
    doi: 10.1007/978-1-59745-401-8_24pubmed: 17951672google scholar: lookup
  25. Ross TN, Kisiday JD, Hess T, McIlwraith CW. Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide.. Osteoarthritis Cartilage 2012 Dec;20(12):1583-90.
    doi: 10.1016/j.joca.2012.08.008pubmed: 22917743google scholar: lookup
  26. Clutterbuck AL, Mobasheri A, Shakibaei M, Allaway D, Harris P. Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation.. Ann N Y Acad Sci 2009 Aug;1171:428-35.
  27. Wagner B, Freer H. Development of a bead-based multiplex assay for simultaneous quantification of cytokines in horses.. Vet Immunol Immunopathol 2009 Feb 15;127(3-4):242-8.
    doi: 10.1016/j.vetimm.2008.10.313pubmed: 19027964google scholar: lookup
  28. Malda J, de Grauw JC, Benders KE, Kik MJ, van de Lest CH, Creemers LB, Dhert WJ, van Weeren PR. Of mice, men and elephants: the relation between articular cartilage thickness and body mass.. PLoS One 2013;8(2):e57683.
  29. Delco ML, Kennedy JG, Bonassar LJ, Fortier LA. Post-traumatic osteoarthritis of the ankle: A distinct clinical entity requiring new research approaches.. J Orthop Res 2017 Mar;35(3):440-453.
    doi: 10.1002/jor.23462pmc: PMC5467729pubmed: 27764893google scholar: lookup
  30. Shi H, Chi H. Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity.. Front Immunol 2019;10:2716.
    doi: 10.3389/fimmu.2019.02716pmc: PMC6917616pubmed: 31921097google scholar: lookup
  31. Yang S, Zhang X, Chen J, Dang J, Liang R, Zeng D, Zhang H, Xue Y, Liu Y, Wu W, Zhao J, Wang J, Pan Y, Xu H, Sun B, Huang F, Lu Y, Hsueh W, Olsen N, Zheng SG. Induced, but not natural, regulatory T cells retain phenotype and function following exposure to inflamed synovial fibroblasts.. Sci Adv 2020 Oct;6(44).
    pmc: PMC7608803pubmed: 33115734doi: 10.1126/sciadv.abb0606google scholar: lookup
  32. Li H, Wang D, Yuan Y, Min J. New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis.. Arthritis Res Ther 2017 Nov 10;19(1):248.
    doi: 10.1186/s13075-017-1454-2pmc: PMC5681770pubmed: 29126436google scholar: lookup
  33. Young DA, Barter MJ, Wilkinson DJ. Recent advances in understanding the regulation of metalloproteinases.. F1000Res 2019;8.
  34. Fortier LA, Motta T, Greenwald RA, Divers TJ, Mayr KG. Synoviocytes are more sensitive than cartilage to the effects of minocycline and doxycycline on IL-1alpha and MMP-13-induced catabolic gene responses.. J Orthop Res 2010 Apr;28(4):522-8.
    doi: 10.1002/jor.21006pubmed: 19813262google scholar: lookup
  35. Ko JH, Kang YM, Yang JH, Kim JS, Lee WJ, Kim SH, Yang IH, Moon SH. Regulation of MMP and TIMP expression in synovial fibroblasts from knee osteoarthritis with flexion contracture using adenovirus-mediated relaxin gene therapy.. Knee 2019 Mar;26(2):317-329.
    doi: 10.1016/j.knee.2019.01.010pubmed: 30770167google scholar: lookup
  36. Kuroki K, Cook JL, Kreeger JM, Tomlinson JL. The effects of TIMP-1 and -2 on canine chondrocytes cultured in three-dimensional agarose culture system.. Osteoarthritis Cartilage 2003 Sep;11(9):625-35.
    doi: 10.1016/S1063-4584(03)00116-Xpubmed: 12954233google scholar: lookup
  37. Nguyen JK, Austin E, Huang A, Mamalis A, Jagdeo J. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets.. Arch Dermatol Res 2020 Mar;312(2):81-92.
    doi: 10.1007/s00403-019-01972-3pmc: PMC7008089pubmed: 31493000google scholar: lookup
  38. van Meegeren ME, Roosendaal G, Jansen NW, Wenting MJ, van Wesel AC, van Roon JA, Lafeber FP. IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage.. Osteoarthritis Cartilage 2012 Jul;20(7):764-72.
    doi: 10.1016/j.joca.2012.04.002pubmed: 22503813google scholar: lookup
  39. Hashizume M, Mihara M. The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis.. Arthritis 2011;2011:765624.
    doi: 10.1155/2011/765624pmc: PMC3199948pubmed: 22046525google scholar: lookup
  40. Legendre F, Dudhia J, Pujol JP, Bogdanowicz P. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression.. J Biol Chem 2003 Jan 31;278(5):2903-12.
    doi: 10.1074/jbc.M110773200pubmed: 12419823google scholar: lookup
  41. Wiegertjes R, van de Loo FAJ, Blaney Davidson EN. A roadmap to target interleukin-6 in osteoarthritis.. Rheumatology (Oxford) 2020 Oct 1;59(10):2681-2694.
  42. Biggioggero M, Crotti C, Becciolini A, Favalli EG. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.. Drug Des Devel Ther 2019;13:57-70.
    doi: 10.2147/DDDT.S150580pmc: PMC6304084pubmed: 30587928google scholar: lookup
  43. Sarkar S, Justa S, Brucks M, Endres J, Fox DA, Zhou X, Alnaimat F, Whitaker B, Wheeler JC, Jones BH, Bommireddy SR. Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis.. Clin Exp Immunol 2014 Sep;177(3):652-61.
    doi: 10.1111/cei.12376pmc: PMC4137849pubmed: 24813051google scholar: lookup
  44. Raghu H, Lepus CM, Wang Q, Wong HH, Lingampalli N, Oliviero F, Punzi L, Giori NJ, Goodman SB, Chu CR, Sokolove JB, Robinson WH. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.. Ann Rheum Dis 2017 May;76(5):914-922.
  45. Gschwandtner M, Derler R, Midwood KS. More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis.. Front Immunol 2019;10:2759.
    doi: 10.3389/fimmu.2019.02759pmc: PMC6923224pubmed: 31921102google scholar: lookup
  46. Nie Y, Huang H, Guo M, Chen J, Wu W, Li W, Xu X, Lin X, Fu W, Yao Y, Zheng F, Luo ML, Saw PE, Yao H, Song E, Hu H. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.. Clin Cancer Res 2019 Jul 1;25(13):3873-3886.
    doi: 10.1158/1078-0432.CCR-18-3421pubmed: 30890553google scholar: lookup
  47. Chen L, Zhang Q, Yu C, Wang F, Kong X. Functional roles of CCL5/RANTES in liver disease. Liv. Res. 2020;4:28–34.
  48. Yoshitomi H. Regulation of Immune Responses and Chronic Inflammation by Fibroblast-Like Synoviocytes.. Front Immunol 2019;10:1395.
    doi: 10.3389/fimmu.2019.01395pmc: PMC6593115pubmed: 31275325google scholar: lookup
  49. You Y, Li Y, Li M, Lei M, Wu M, Qu Y, Yuan Y, Chen T, Jiang H. Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.. Clin Exp Immunol 2018 Jan;191(1):60-73.
    doi: 10.1111/cei.13044pmc: PMC5721255pubmed: 28868628google scholar: lookup
  50. Tu J, Hong W, Zhang P, Wang X, Körner H, Wei W. Ontology and Function of Fibroblast-Like and Macrophage-Like Synoviocytes: How Do They Talk to Each Other and Can They Be Targeted for Rheumatoid Arthritis Therapy?. Front Immunol 2018;9:1467.
    doi: 10.3389/fimmu.2018.01467pmc: PMC6028561pubmed: 29997624google scholar: lookup

Citations

This article has been cited 8 times.
  1. Keller LE, Tait Wojno ED, Begum L, Fortier LA. Interleukin-6 neutralization and regulatory T cells are additive in chondroprotection from IL-1β-induced inflammation. J Orthop Res 2023 May;41(5):942-950.
    doi: 10.1002/jor.25453pubmed: 36205183google scholar: lookup
  2. Ma X, Yinwang E, Chai X, Wang F, Chen Z, Wang S, Zhou H, Xue Y, Lei J, Chen F, Li H, Chen S, Zhao S, Wang K, Chen L, Gao J, Ye Z, Lin N. Musculoskeletal Diseases: Mechanisms and Therapeutic Advances. MedComm (2020) 2025 Dec;6(12):e70519.
    doi: 10.1002/mco2.70519pubmed: 41357670google scholar: lookup
  3. Ahn J, Kim B, Bello AB, Moon JJ, Arai Y, Lee SH. Regenerative Functions of Regulatory T Cells and Current Strategies Utilizing Mesenchymal Stem Cells in Immunomodulatory Tissue Regeneration. Tissue Eng Regen Med 2025 Feb;22(2):167-180.
    doi: 10.1007/s13770-024-00690-wpubmed: 39804546google scholar: lookup
  4. Elkhenany HA, Linardi RL, Ortved KF. Differential modulation of inflammatory cytokines by recombinant IL-10 in IL-1β and TNF-α ̶ stimulated equine chondrocytes and synoviocytes: impact of washing and timing on cytokine responses. BMC Vet Res 2024 Dec 2;20(1):546.
    doi: 10.1186/s12917-024-04403-2pubmed: 39623412google scholar: lookup
  5. Wen Z, Qiu L, Ye Z, Tan X, Xu X, Lu M, Kuang G. The role of Th/Treg immune cells in osteoarthritis. Front Immunol 2024;15:1393418.
    doi: 10.3389/fimmu.2024.1393418pubmed: 39364408google scholar: lookup
  6. Weng L, Luo Y, Luo X, Yao K, Zhang Q, Tan J, Yin Y. The common link between sleep apnea syndrome and osteoarthritis: a literature review. Front Med (Lausanne) 2024;11:1401309.
    doi: 10.3389/fmed.2024.1401309pubmed: 39234045google scholar: lookup
  7. Ju Y, Jin C, Chen S, Wang J, Li C, Wang X, Wang P, Yue L, Jiang X, Tuohetaerbaike B, Li Y, Sheng Y, Qimanguli W, Wang J, Chen F. Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism. Front Cell Infect Microbiol 2023;13:1240516.
    doi: 10.3389/fcimb.2023.1240516pubmed: 37908762google scholar: lookup
  8. Cimini D, Boccella S, Alfano A, Stellavato A, Paino S, Schiraldi C, Guida F, Perrone M, Donniacuo M, Tirino V, Desiderio V, Rinaldi B. Evaluation of unsulfated biotechnological chondroitin in a knee osteoarthritis mouse model as a potential novel functional ingredient in nutraceuticals and pharmaceuticals. Front Bioeng Biotechnol 2022;10:934997.
    doi: 10.3389/fbioe.2022.934997pubmed: 36466352google scholar: lookup